1 0 3 3 a r t I C l e S DA neurotransmission participates in complex brain functions, including the initiation and planning of motor activity, the identification of salient stimuli that predict reward, and the spatio-temporal organization of goal-oriented behaviors 1 . The importance of central dopaminergic systems has been appreciated for decades as a result of the motor, cognitive, emotional and social deficits that constitute the hallmarks of frequent human disorders, such as Parkinson's disease, schizophrenia, attention-deficit and hyperactivity disorder, and compulsive drug abuse 2,3 . Natural rewards, such as food or sex, exert their reinforcing properties by eliciting a fast increase in extracellular DA in the brain 4 . Drugs of abuse take advantage of this system by increasing extracellular DA to levels that greatly exceed those triggered by any natural reward 3 . Addictive drugs use various mechanisms to raise extracellular DA levels. For example, nicotine and opiates increase DA neuron firing, cocaine blocks DA reuptake, and amphetamine and other phenylethylamines release DA from DA terminals 5 . Research in humans 3 , monkeys 6 and rodents 7 has shown that increased vulnerability to drug addiction correlates with reduced availability of striatal D 2 receptors, and healthy non-abusing volunteers expressing low levels of D 2 receptors report more pleasant experiences when taking drugs of abuse 8, 9 . These results appear to conflict with studies performed in mutant mice that lack D 2 receptors, which showed reduced or absent reinforcing properties for drugs of abuse, such as cocaine, morphine and ethanol [10] [11] [12] [13] [14] . This apparent contradiction may result from the different roles that D 2 receptors have in distinct neuronal types.
DA neurotransmission participates in complex brain functions, including the initiation and planning of motor activity, the identification of salient stimuli that predict reward, and the spatio-temporal organization of goal-oriented behaviors 1 . The importance of central dopaminergic systems has been appreciated for decades as a result of the motor, cognitive, emotional and social deficits that constitute the hallmarks of frequent human disorders, such as Parkinson's disease, schizophrenia, attention-deficit and hyperactivity disorder, and compulsive drug abuse 2, 3 . Natural rewards, such as food or sex, exert their reinforcing properties by eliciting a fast increase in extracellular DA in the brain 4 . Drugs of abuse take advantage of this system by increasing extracellular DA to levels that greatly exceed those triggered by any natural reward 3 . Addictive drugs use various mechanisms to raise extracellular DA levels. For example, nicotine and opiates increase DA neuron firing, cocaine blocks DA reuptake, and amphetamine and other phenylethylamines release DA from DA terminals 5 . Research in humans 3 , monkeys 6 and rodents 7 has shown that increased vulnerability to drug addiction correlates with reduced availability of striatal D 2 receptors, and healthy non-abusing volunteers expressing low levels of D 2 receptors report more pleasant experiences when taking drugs of abuse 8, 9 . These results appear to conflict with studies performed in mutant mice that lack D 2 receptors, which showed reduced or absent reinforcing properties for drugs of abuse, such as cocaine, morphine and ethanol [10] [11] [12] [13] [14] . This apparent contradiction may result from the different roles that D 2 receptors have in distinct neuronal types.
The majority of D 2 receptors are located on postsynaptic nondopaminergic neurons that integrate several brain circuits. In addition, D 2 autoreceptors present in the somas, dendrites and terminals of DA neurons exert an ultra-short negative feedback regulation of DA transmission [15] [16] [17] [18] [19] . Although somatodendritic D 2 autoreceptors modulate firing rate 15, 17, 18 , those located on nerve terminals regulate DA synthesis and release 16, 19 . Locally released DA inhibits the activity of DA neurons, and therefore inhibits the subsequent release of DA in terminal regions 17, 20 . In addition, activation of autoreceptors present on dopaminergic terminals diminishes terminal excitability and the probability of further DA release 20 . Because DA autoreceptors produce feedback inhibition of DA transmission, impaired autoreceptor function would likely lead to increased DA neuron excitability and augmented DA release, posing a risk factor for impulsive behavior, hyperactivity, drug addiction and vulnerability to relapse. In fact, a recent study found that highly impulsive individuals are characterized by diminished midbrain autoreceptor availability 21 .
In vivo blockade or stimulation of D 2 autoreceptors has been hampered by the fact that receptor-targeted compounds also interact with postsynaptic D 2 receptors, which are more abundantly expressed in all DA target areas. In addition, the pharmacological properties of D 2 receptors are very similar to those of D 3 and D 4 receptors (all members of the D 2 -like subfamily), and, as a result, stimulation or inhibition of the individual D 2 -like receptor subtypes in vivo is impractical 22 . Genetic approaches undertaken to study the functional role of D 2 autoreceptors have also failed to settle these issues. Although mutant 1 0 3 4 VOLUME 14 | NUMBER 8 | AUGUST 2011 nature neurOSCIenCe a r t I C l e S mice lacking D 2 receptors have revealed some of the ex vivo properties of D 2 autoreceptors 23 , Drd2 −/− mice have not been used to specifically study D 2 autoreceptor function because the simultaneous loss of all preand postsynaptic D 2 receptors elicits a number of diverse overlapping phenotypes (for example, Drd2 −/− mice are dwarfs owing to deficits in the growth hormone axis 24 ). Although impaired DA autoreceptor function may substantially modify motor performance, motivational states and subjective values of reinforcers, the in vivo contribution of this inhibitory system to DA-mediated behaviors remains unknown. To circumvent this difficulty, we generated conditional mutant mice by deleting the D 2 receptor gene (Drd2) in dopaminergic neurons (autoDrd2KO mice). AutoDrd2KO mice lacked D 2 autoreceptors and expressed postsynaptic D 2 receptors normally on non-dopaminergic neurons in all of the brain and peripheral regions that we examined. This mouse model allowed us to directly evaluate the importance of D 2 autoreceptor inhibitory control in dopaminergic neurotransmission, DA-mediated locomotor activity and the rewarding properties of food and cocaine.
RESULTS

Lack of autoinhibition in DA neurons from autoDrd2KO mice
We generated autoDrd2KO mice by consecutively breeding Drd2 loxP/loxP and Dat +/IRES−cre mice ( Fig. 1a and Supplementary  Fig. 1 ). These two C57BL/6J congenic (≥10) parental strains were overtly normal in all of the tested parameters ( Supplementary  Fig. 2 (Fig. 1b) , but no signal was detected in midbrain sections. Identical results were obtained by in situ hybridization using a Drd2 exon 2 antisense riboprobe (Supplementary Fig. 3a) . Thus, autoDrd2KO mice are authentic D 2 autoreceptor knockout mice (Fig. 1c) . AutoDrd2KO mice are viable and a broad physical and anatomical inspection did not reveal any overt phenotypic differences from their Drd2 loxP/loxP littermates (Supplementary Fig. 3b) .
The soma and dendrites of midbrain DA neurons express autoreceptors that modulate firing rates by inducing inhibitory currents 15, 17 . Voltage-clamp recordings (−55 mV) from midbrain dopaminergic neurons revealed that the D 2 -like (includes D 2 , D 3 and D 4 receptors) agonist quinpirole (0.2 µM) induced a slow hyperpolarizing current in neurons obtained from Drd2 loxP/loxP mice, but not from autoDrd2KO mice (Fig. 1d,e) , whereas dopaminergic neurons recorded from Drd2 loxP/loxP and autoDrd2KO midbrain slices responded equally to the GABA B agonist baclofen (5 µM). A train of electrical stimulation, applied in the presence of AMPA, NMDA, GABA A and α-adrenergic blockers evoked inhibitory postsynaptic currents (IPSCs) that were reduced by the D 2 -like receptor antagonist sulpiride (150 nM) in Drd2 loxP/loxP mouse neurons, but not in those from autoDrd2KO mice (Fig. 1f,g ). Thus, endogenous DA release acting on somatodendritic D 2 autoreceptors constitutes a major component of the total G proteincoupled receptor-mediated inhibitory response in control mice (Fig. 1g) . The lack of an effect of quinpirole and sulpiride on midbrain dopaminergic neurons of autoDrd2KO mice strongly suggests that D 2 is the predominant D 2 -like autoreceptor responsible for feedback inhibition of midbrain dopaminergic neuronal activity via somatodendritic actions. Notably, the IPSC density that we recorded from autoDrd2KO mouse neurons was similar to what we observed in neurons from control mice treated with sulpiride ( Fig. 1g) , indicating that no other G protein-coupled receptor-mediated inhibitory mechanism compensated for the lack of D 2 autoreceptors. Together, these results suggest that the endogenous DA-mediated inhibitory regulation of DA neuron firing is severely impaired in autoDrd2KO mice. a r t I C l e S terminals regulate DA release at a subsecond resolution. The amount of DA released by a single 300-µA pulse was significantly higher (~60%, P < 0.001) in autoDrd2KO mice than in controls (Fig. 2a) . Greater DA release was observed at all stimulus intensities (Fig. 2b) . In this singlepulse procedure, sulpiride (2 µM) did not affect DA release in striatal slices of either genotype (Fig. 2c) , as was previously reported 26, 27 .
The D 2 -like agonist quinpirole strongly inhibited electrically stimulated DA release in dorsal striatum of Drd2 loxP/loxP mice in a concentration-dependent manner with a half maximal inhibitory concentration of 19 ± 0.3 nM (Fig. 2d) . We found that DA transients in autoDrd2KO mice were insensitive to quinpirole, indicating that D 2 autoreceptors were absent from DA terminals (Fig. 2d) . We tested whether the increased DA release could result from a larger releasable pool of DA generated by the lack of DA synthesis inhibition in DA terminals 28 . Tyrosine hydroxylase activity, assessed by l-3,4-dihydroxyphenylalanine (l-DOPA) accumulation, in striata from autoDrd2KO mice was twice that observed in Drd2 loxP/loxP littermates (Fig. 2e) . Notably, quinpirole (0.5 mg per kg of body weight) decreased tyrosine hydroxylase activity in Drd2 loxP/loxP , but not in autoDrd2KO mice (Fig. 2e) , suggesting that the D 2 receptor is the only D 2 -like receptor to participate in the feedback inhibition of DA synthesis. Striatal DA content was similar in mice of both genotypes (Drd2 loxP/loxP , 68.2 ± 10.3 pmol per mg of tissue; autoDrd2KO, 64.1 ± 7.6 pmol per mg of tissue).
AutoDrd2KO mice display locomotor hyperactivity
AutoDrd2KO mice showed increased locomotor activity and normal habituation in a novel open field (Fig. 3a) . Hyperactivity resulted from higher frequency of movement initiations (Drd2 loxP/loxP , 325.0 ± 39.3 initiations; autoDrd2KO, 531.7 ± 29.7 initiations; one-way ANOVA genotype: (Fig. 3b) , which is different from other hyperactive mouse models [29] [30] [31] . On subsequent days, when the open field constituted a somewhat familiar environment, locomotor scores diminished in both genotypes, but always remained between 40 to 60% higher in autoDrd2KO mice (Fig. 3c) .
We further studied autoDrd2KO mice in other approach/avoidance conflicts. Both autoDrd2KO and Drd2 loxP/loxP mice avoided entering the open arms of an elevated plus maze and the lit compartment of a light/dark preference arena to a similar extent ( Supplementary  Fig. 4a-d) . In a novel object test, mice of both genotypes showed similar reaction times (Supplementary Fig. 4e ). Finally, autoDrd2KO mice Fig. 4f ). Altogether, autoDrd2KO mice were hyperactive, but showed normal risk assessment and motor coordination and no signs of anxiety-like behavior or inattention. Low doses of quinpirole decreased the locomotor activity of Drd2 loxP/loxP mice, but not of autoDrd2KO mice (Fig. 3d) , indicating that stimulation of D 2 autoreceptors diminishes locomotor activity probably by reducing DA neuron firing and DA release.
AutoDrd2KO mice display increased sensitivity to cocaine DA transporters (DATs) and D 2 autoreceptors work together to limit extracellular DA levels via rapid DA reuptake and inhibition of neuronal firing and DA release, respectively 26, 32, 33 . To examine the kinetics of DAT-mediated DA uptake in the absence of D 2 autoreceptors, we used single-pulse stimulation FSCV in dorsal striatal slices from autoDrd2KO mice and their Drd2 loxP/loxP littermates. The DAT inhibitor cocaine (10 µM) increased stimulation-induced DA levels in mice of both genotypes (Fig. 4a) and similar effects were observed with the DAT blocker methylphenidate (data not shown). DA clearance from the extracellular space followed the same kinetics in autoDrd2KO and Drd2 loxP/loxP mice (Fig. 4b) . Similarly, both DAT inhibitors decreased DA clearance (increasedτ values; Fig. 4b ) to similar extents in slices from both genotypes. Thus, DAT-mediated reuptake remains normal in autoDrd2KO mice despite the complete loss of D 2 autoreceptors.
We next sought to assess the in vivo effects of cocaine. AutoDrd2KO mice were supersensitive to the locomotor stimulant effects of cocaine. At 5 mg per kg (intraperitoneal), cocaine increased the locomotor activity of autoDrd2KO mice 1.4-fold and had no effect on Drd2 loxP/loxP mice (Fig. 4c) . At 15 mg per kg, cocaine increased locomotor activity of Drd2 loxP/loxP and autoDrd2KO mice by 2.8-and 3.8-fold, respectively (Fig. 4c) . The rewarding effect of cocaine was evaluated using a conditioned place preference procedure. At 5 mg per kg (intraperitoneal), cocaine induced robust conditioned responses, increasing the time spent on the drug-paired floor in mice of both genotypes (Fig. 4d) . However, only autoDrd2KO mice showed conditioned responses when 0.5 mg per kg cocaine doses were used (Fig. 4e) . These results indicate that reward sensitivity for cocaine is increased in the absence of D 2 autoreceptors.
Supramaximal DA release in autoDrd2KO mice
To investigate the functional consequences of the lack of D 2 autoreceptors in the regulation of DA release during sustained activity, 30-pulse stimulus trains at 10 Hz (10-min intertrain intervals) were delivered and DA levels were measured with FSCV in dorsal striatal slices ( Fig. 5a ; note the different temporal profile of DA concentration changes compared with single pulse in Fig. 2a) . In Drd2 loxP/loxP slices, stimulus trains evoked a characteristic peak and steady-state DA profile that shifted to a sustained high DA level profile on sulpiride application. In autoDrd2KO mice, train-evoked DA levels were not only sustained, a r t I C l e S but were also increased during stimulation to supramaximal levels that were insensitive to sulpiride (Fig. 5b) . Thus, D 2 autoreceptors exert an inhibitory control of phasic DA release via rapid feedback inhibition of release combined with inhibition of DA synthesis. Acute D 2 receptor blockade only prevents the rapid release inhibition, whereas the full extent of D 2 autoreceptor actions can be seen in autoDrd2KO mice. The loss of D 2 autoreceptor modulation observed in autoDrd2KO mice also appears to have noticeable in vivo effects. AutoDrd2KO mice were supersensitive to the inhibitory effects of the D 2 receptor antagonist haloperidol. At 0.1 mg per kg, haloperidol reduced locomotor activity of Drd2 loxP/loxP and autoDrd2KO mice by 38% and 76%, respectively (Fig. 5c) . At a higher dose of haloperidol (0.6 mg per kg), locomotor activity was further reduced by 85% in Drd2 loxP/loxP mice, whereas autoDrd2KO mice were rendered mostly akinetic. These findings are consistent with the idea that haloperidol blockade of postsynaptic D 2 receptors competes with a concurrent rise in extracellular DA elicited by D 2 autoreceptor blockade in normal mice. Given that this latter effect does not occur when D 2 autoreceptors are absent, autoDrd2KO mice are supersensitive to the effect of this drug.
Increased motivation to work for food in autoDrd2KO mice
Given that DA participates in reward-guided behavior 1, 34, 35 , we sought to examine the effects of D 2 autoreceptor loss in motivation to perform rewarded operant behaviors. Food-restricted mice of both genotypes were subjected to a fixed ratio schedule (FR3) that escalated every 3 d to FR10, FR30 and FR100. Up to FR30, all mice worked to obtain approximately 120 food pellets of 20 mg each and showed no differences in satiety and motivation to self-administer food (Fig. 6a) . At FR100, however, Drd2 loxP/loxP mice decreased the number of pellets obtained (abandoned after pressing for 2.8 ± 0.3 h), whereas autoDrd2KO mice continued pressing the reward-paired lever for more than 4.4 ± 0.8 h and obtained a number of pellets that was even higher than those obtained under the lower fixed ratio value regimes (Fig. 6a) .
A progressive ratio (PR2 n ) procedure indicated that these differences were due to greater motivation in autoDrd2KO mice. AutoDrd2KO mice outperformed their control siblings by pressing many more times on the lever (Fig. 6b) and obtaining more pellets (Fig. 6b) . Mice of both genotypes exhibited a similar profile of loss of responding following cessation of reward delivery (Fig. 6c) indicating that the increased operant responding in autoDrd2 −/− mice is not due to hyperactivity or differences in extinction, but rather to higher motivation to work for food.
DISCUSSION
Our data indicate that targeted inactivation of Drd2 specifically in Dat (also known as Slc6a3)-expressing neurons induces a total loss of Drd2 expression in midbrain DA neurons and, consequently, prevents DA-mediated IPSCs in these neurons and DA-mediated autoinhibition of DA release in striatal DA terminals. Thus, although five subtypes of DA receptors orchestrate all DA postsynaptic responses, DAmediated autoinhibition of DA neuron activity, DA release and DA synthesis appear to be mainly conveyed by the D 2 receptor subtype. There has been a controversy in the literature, with reports suggesting the participation of D 3 receptors acting as autoreceptors that control DA neurotranmission 21, 36, 37 and others presenting evidence against this possibility 22 . Our results settle this debate by demonstrating that no other member of the D 2 -like subfamily is able to compensate for the loss of D 2 autoreceptor function. Another controversy that autoDrd2KO mice help to clarify is whether D 2 autoreceptors regulate DA uptake, as has been suggested 32, 38, 39 . Our analysis of DA transient decay and the effects of the DAT inhibitors cocaine and methylphenidate shows that DAT-mediated DA reuptake is not altered in the absence of D 2 autoreceptors. Moreover, the exaggerated level of extracellular DA detected during sustained afferent activation that mimics phasic DA release revealed the tight regulatory control that D 2 autoreceptors normally exert on tuning DA release. Despite normal DAT function, autoDrd2KO mice were supersensitive to cocaine, perhaps owing to the combined additive effects of DAT blockade and absence of presynaptic inhibition that further elevates extracellular DA and maximizes stimulation of postsynaptic DA receptors.
In contrast with full D 2 receptor knockout mice, which lack D 2 receptors in all cell types and have reduced locomotor activity 40, 41 and impaired reward responses for cocaine 10, 13 and other drugs of abuse 11, 12, 14 , autoDrd2KO mice displayed hyperactivity in novel and familiar environments and enhanced motivation to seek reward. The phenotypic differences observed between Drd2 −/− and autoDrd2KO mice highlight the value of cell-specific conditional mutant mouse models for determining the importance of the same gene product in different neurons. It is conceivable that the phenotypes observed in each mutant mouse model are the results of the primary absence of D 2 receptors combined with secondary compensatory mechanisms that are likely to develop with chronic receptor loss, and, in the case of autoDrd2KO mice, chronic hyperdopaminergia.
It has been proposed that lower D 2 receptor levels in humans 3 , monkeys 6 and rodents 7 predispose them to compulsive drug selfadministration. In this context, it has been hypothesized that repetitive drug use compensates for the otherwise decreased activation of postsynaptic D 2 receptors participating in reward circuits 3, 8 . However, it is not clear from those studies whether lower D 2 receptor availability is a result of reduced D 2 receptor density or increased DA release competing with the labeled ligand. In addition, downregulation of postsynaptic D 2 receptors may result as a compensatory mechanism for excessive dopaminergic transmission. We found that autoDrd2KO mice are supersensitive to the rewarding properties of cocaine and have excessive dopaminergic transmission, suggesting that low levels of presynaptic D 2 autoreceptors can also predict enhanced susceptibility to drug-seeking and drug abuse. In fact, a recent human study found that low levels of D 2 receptors in the midbrain correlated with higher impulsivity and stronger subjective desire for amphetamine 21 . We found increased locomotor responses and conditioned place preference for cocaine in autoDrd2KO mice, indicating that reduced D 2 autoreceptor-mediated inhibition of DA cell firing and DA release a r t I C l e S enhance the postsynaptic effects elicited by drugs that increase extracellular DA concentration. AutoDrd2KO mice also showed enhanced motivation to work for food. In the escalated fixed ratio experiment in which the mice had to press a lever 100 times to receive one pellet, autoDrd2KO mice not only outperformed their control littermates, but also developed compulsive bar-pressing behavior, as they worked to obtain many more pellets than those required for their daily food intake needs (Fig. 6a) . Thus, autoDrd2KO mice may constitute a valuable model for connecting the neurobiology of motivation with that of compulsive behavior. Altogether, our results highlight the critical regulatory role that D 2 autoreceptors have in DA neurotransmission and suggest that transcriptional regulation of Drd2 in DA neurons may contribute to the individual behavioral reactions toward natural rewards and drugs of abuse.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
ONLINE METhODS
Generation and breeding of conditional Drd2 mutant mice. We generated mutant mice carrying two targeted loxP sites flanking Drd2 exon 2 (Drd2 tm1Mrub , also known as Drd2 loxP/loxP ) as described in Supplementary Figure 1 We genotyped mice by PCR using primers to detect the presence of the Drd2 loxP allele (5′-GCT TCA CAG TGT GCT GCC TA-3′ and 5′-CCA TTG CTG CCT CTA CCA AG-3′) and the Cre recombinase gene sequence (5′-AAA ATT TGC CTG CAT TAC CG-3′ and 5′-GCA TAA CCA GTG AAA CAG CAT TGC TG-3′). We used adult male mice except where noted.
Animal husbandry. We housed same-sex animals of mixed genotypes in groups of up to six animals per cage in an animal room at 22 °C under a 12-h light/dark cycle (lights on at 7:00 a.m.), with ad libitum access to food and water (except when noted). We conducted all testing during the light period and between 11:00 a.m. In situ hybridization with digoxigenin-labeled RNA probes. We processed 16-µm cryostat sections for in situ hybridization according to previously described protocols 43, 44 . We prepared an in vitro transcribed digoxigenin-UTPlabeled antisense riboprobe for mouse Drd2 exon 2 according to instructions of the manufacturer (Roche).
Electrophysiology. We prepared 220-µm horizontal slices from midbrain of autoDrd2KO mice and Drd2 loxP/loxP control littermates (3-5 months old). Slices were recovered for 20 min at 33 °C and placed in a submerged chamber perfused at 2 ml min −1 with standard artificial cerebrospinal fluid containing 124 mM NaCl, 1 mM NaH 2 PO 4 , 2.5 mM KCl, 1.3 mM MgCl 2 , 2.5 mM CaCl 2 , 20 mM glucose, and 26.2 mM NaHCO 3 at 31 °C using an in-line heater (Harvard Apparatus). We performed visualized whole-cell patch-clamp recording using recording electrodes, with a resistance ~2 MΩ, that were filled with a solution containing 115 mM potassium methylsulfate, 10 mM BAPTA, 10 mM sodium phosphocreatine, 10 mM KCl, 1.5 MgCl 2 , 10 mM HEPES, 4 mM Na-ATP, and 0.4 mM Na-GTP (pH 7.2-7.3). We used interpeduncular fossa and medial terminal nucleus as landmarks to locate midbrain DA neurons, which were further confirmed by spontaneous activities at 2-5 Hz and I h current. Cells were voltage clamped at −55 mV and the currents were low-pass filtered at 1 kHz and digitized at 5 kHz. For extracellular stimulation, standard patch pipettes filled with artificial cerebrospinal fluid were placed ~100 µm caudal to the cell being recorded. We applied a total of 10 1-ms-long pulses at 100 Hz to evoke a postsynaptic slow IPSC in the presence of NBQX (10 µM), MK-801 (10 µM), gabazine (5 µM) and prazosin (100 nM).
Fast-scan cyclic voltammetry. FSCV was performed in mouse coronal slices containing the dorsal striatum 45 . We prepared cylindrical carbon-fiber microelectrodes (75-100 µm of exposed fiber) with T650 fibers (6-µm diameter) inserted into a glass pipette. The carbon-fiber electrode was held at −0.4 V versus Ag/AgCl and periodically a cyclic voltammogram was acquired (100-ms intervals). The applied potential was scanned to +1.2 V and back in a triangular fashion at 400 V s −1 . DA was evoked by single pulse or train stimulations. For single pulse stimulation, we applied a rectangular, electrical pulse (50-600 µA, 0.6 ms per phase, biphasic) every 5 min. For train stimulation, we delivered a 10-Hz train of 30 pulses (600 µA, biphasic) at 10-min intervals. Ten cyclic voltammograms were recorded before stimulation, averaged and subtracted from the cyclic voltammograms collected. Once the extracellular DA response to electrical stimulation was stable for five successive stimulations, we applied drugs to the brain slice via the superfusate. We performed each test in one slice, which served as its own precondition control and the three conditions were recorded in the same recording site from the same animal.
l-DOPA determination. We treated mice with saline or the DOPA-decarboxylase inhibitor NSD-1015 (3-hydroxybenzylhydrazine, 100 mg per kg, intraperitoneal) and killed them after 40 min. We determined l-DOPA and DA contents as described previously 46 by high-performance liquid chromatography coupled with an electrochemical detector. We quantified each striatum separately and then averaged them before performing statistical analysis.
Open field test. We evaluated horizontal locomotion and exploration in a novel open field in activity boxes (Med Associates) for 60 min for 3 consecutive days. We determined total distance, habituation, total ambulatory episodes, average velocity and periphery/center trajectories. In pharmacological experiments, mice received intraperitoneal injections with either saline (154 mM NaCl) or the corresponding drug and then placed in the open field to measure their locomotor activity. When giving haloperidol (Tocris), we recorded mouse activity 20 min after the injection. For quinpirole (Sigma) and cocaine (Sigma), we recorded mouse activity immediately after injections.
Rotarod and elevated plus maze. Performance were described previously 29 . For the rotarod test, we trained mice (n = 6-7) for 3 consecutive days in an elevated rotating rod (Med Associates) at 16 rpm. The third day, 30 min after the last training session, we set mice in an accelerated speed program from 4-40 rpm for 5 min. We measured the latency to the first fall. For the elevated plus maze test, we allowed mice (n = 10-17) to explore the maze for 5 min while being videotaped. We counted one entry only when all four paws were inside the arm and each entry to the center when the mouse left a particular arm.
Light/dark choice test. The light/dark choice test was performed as described previously 47 .
Novel object. The novel object test was performed as described elsewhere 48 . Briefly, we habituated mice for 30 min for 2 consecutive days to 25 cm × 25 cm × 25 cm boxes. On the third day, we placed them in the same boxes for 10 min in the presence of two identical plastic tubes. An hour later, we returned them to the cages and we replaced one of the tubes with a rubber ball of similar size. We measured and plotted the number of times the mouse approached the novel object (head toward the ball and distance less than 2 cm).
Conditioned place preference. We subjected mice to 4 d of conditioning sessions as described previously 49 using cocaine at doses of 5 or 0.5 mg per kg. Previous to conditioning (pretest) mice of both genotypes did not show floor preferences in a paired t test analysis (grid versus floor) as a group. Given that each individual mouse showed a slight preference for one floor type, they were all conditioned to the other floor type. We considered animals to be conditioned if the time spent on the drug-paired floor increased significantly after conditioning in comparison with time on that same floor during pretest (30 min). We analyzed results using repeated-measures ANOVA.
Continuous reinforcement task. We performed experimental conditions and initial training as described previously 50 , but without lever retraction. We maintained mice at 85% of their normal body weight and trained them in an FR1 schedule (one pellet for one press) for 5 d. Finally, we set mice in FR3, FR10, FR30, FR100 food self-administration procedures for 3 d each except the FR100 task that was performed once. During these schedules, we set the time cutoff at 3 min, after which the lever retracted and program ended. Data are averages of the last 2 d ± s.e.m. of the number of pellets obtained (even though no differences were found between the first and following days) and were analyzed using repeated-measures ANOVA.
Progressive ratio task. We trained mice as described above. Then, we trained mice for 2 weeks on a progressive ratio schedule where they had to press a lever in a progressive manner (2 n ) to get successive 20-mg pellets in a 3-min cutoff. We measured the number of pellets obtained and break point (defined as the last series in which a pellet was obtained), number of presses and session time. For statistical analysis, we performed repeated-measures ANOVA, using data from the last 5 d. Extinction schedule: we placed mice in the operant chambers for the two following days in a 60-min extinction program in which no food was delivered.
Statistical analysis. We analyzed data using an ANOVA, and repeated measures where appropriate. Significant ANOVAs were followed up with Fisher LSD test.
